Skip to main content

Attention-Deficit/Hyperactivity Disorder clinical trials at UCSF

3 in progress, 2 open to eligible people

Showing trials for
  • Guided ADHD Therapy for Managing the Extent and Severity of Symptoms

    open to eligible people ages 22-55

    The objective of this study is to assess the safety and effectiveness of an at-home, game-based digital therapy for treating adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD).

    San Francisco, California and other locations

  • PDC-1421 Treatment in Adult Patients With ADHD

    open to eligible people ages 18-70

    Part II is a double-blind, randomized, parallel-group, placebo-controlled study. The primary objective of this trial is to determine the effective doses and treatment period of PDC-1421 Capsule in subjects with ADHD. The secondary objective is to evaluate the safety of PDC-1421 Capsule in subjects receiving PDC-1421 at various dose levels.

    San Francisco, California and other locations

  • dHealth Solution for Improving Parent Adherence to Behavioral Treatment for ADHD

    Sorry, accepting new patients by invitation only

    This study aims to develop, refine and preliminarily test a novel and scalable digital health solution designed to address parent adherence barriers in daily life contexts and increase parent's sustained use of evidence-based parenting strategies.

    San Francisco, California

Our lead scientists for Attention-Deficit/Hyperactivity Disorder research studies include .

Last updated: